CytoDyn Announces Important Milestone Achieved to Initiate Phase IIb Studies

... to address an unmet medical need for serious or life-threatening conditions. PRO 140 belongs to a new class of HIV/AIDS therapeutics -- viral-entry inhibitors -- that are intended to protect healthy cells from viral infection. PRO 140 is a humanized ...

http://www.businesswire.com/news/topix/20130429006626/en